[After stroke or TIA. Double protection by second platelet inhibitor].
D001241:Aspirin / Q000627:therapeutic use*; D000068342:Aspirin, Dipyridamole Drug Combination; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004176:Dipyridamole / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D002546:Ischemic Attack, Transient / Q000517:prevention & control*; D010919:Placebos; D017410:Practice Guidelines as Topic; D012306:Risk; D020521:Stroke / Q000517:prevention & control*
D000068342:Aspirin, Dipyridamole Drug Combination; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D010919:Placebos; D004176:Dipyridamole; D001241:Aspirin
Nach Schlaganfall oder TIA. Doppelter Schutz durch zweiten Plättchenhemmer.